Award & Recognitions

ScinoPharm Award & Recognitions

 

Year Description
May 2021 Recognized as Top CMOs IN APAC 2021 by《Pharma Tech Outlook》
May 2021 Recognized as Best Pharmaceutical R&D & Manufacturing Company – Asia by 《Acquisition International》
December 2019 Granted the Excellence in Workplace Health and Safety Award
November 2019 Received the Authorized Economic Operator Accreditation
May 2018 Rated top 5% in the 4th “Corporate Governance Evaluation” by Taiwan Stock Exchange Corporation
December 2017 Awarded second prize in the “Best Investor Relations Service in the Greater China Region” category in the biotechnology industry by IR Magazine, a global investor relations magazine for professionals.
August 2017 Awarded the 2016 “CSR Corporate Citizenship Award” by CommonWealth Magazine
July 2017 Awarded the Company of the Year in the 105th import/export performance by Bureau of Foreign Trade, Ministry of Economic Affairs
December 2016 Received three Authorized Economic Operators (AEO) certification by Customs Administration, Ministry of Finance
November 2016 Awarded the 2016 Excellence in Workplace Health and Safety Award issued by Southern Taiwan Science Park
July 2016 Awarded the 2016 Taiwan API Manufacturing Company of the Year by Frost & Sullivan
June 2016 Rated top 5% in the 2nd “Corporate Governance Evaluation” by Taiwan Stock Exchange Corporation
August 2015 Awarded the “Citizenship Award” for “Top 100 CSR” by CommonWealth Magazine
July 2015 Awarded the Company of the Year in the 103rd import/export performance by Bureau of Foreign Trade, Ministry of Economic Affairs
June 2015 Rated top 5% in the first “Corporate Governance Evaluation” by Taiwan Stock Exchange Corporation
June 2015 Awarded 4th “National Industrial Innovation Award” by the Ministry of Economic Affairs
April 2015 Rated A++ for two consecutive years in the “Information Disclosure and Transparency” Ranking results by Taiwan Stock Exchange Corporation
October 2014 Recognized as one of Most Honored Companies in Asia by the authoritative financial magazine ‘Institutional Investor’; the only Taiwanese biotech company to receive such an award.
October 2014 Ranked as the top Taiwan biotech pharmaceutical corporation in CommonWealth Magazine’s Benchmark Enterprise survey for two consecutive years
June 2014 Rated A++ in the 11th Information Disclosure and Transparency Ranking results by Taiwan Stock Exchange Corporation
December 2013 Recognized as an Authorized Economic Operator (AEO) by the Taiwan Ministry of Finance
October 2013 Ranked as the top Taiwan biotech pharmaceutical corporation in CommonWealth Magazine’s Benchmark Enterprise survey
September 2013 Awarded “102nd National Invention and Creation Award” by the Intellectual Property Office, Taiwan Ministry of Economic Affairs.
January 2013 Ranked as one of 79 A+ corporations in Taiwan by Global Views Monthly
November 2012 Received management systems accreditation by the Taiwan Responsible Care Association (TRCA) in six categories for the second time, including process safety, employee safety, product safety, and emergency response.
August 2012 Ranked as the number two Taiwan biotech pharmaceutical corporation in CommonWealth Magazine’s Benchmark Enterprise survey
July 2012 Awarded “Outstanding Bio Industry Golden Award” by the Bio Taiwan Industry Organization
November 2011 Received “Top 100 Innovation Award” by the Industrial Development Bureau, Taiwan Ministry of Economic Affairs
September 2010 Recognized as an Authorized Economic Operator (AEO) by the Taiwan Ministry of Finance
September 2010 Awarded “Industry Contribution Award” by the Taiwan Chemical Industry Association
August 2010 Received a 5-year “Taiwan Occupational Safety and Hygiene Management System” (TOSHMS) performance accreditation from the Council of Labor Affairs
December 2009 Awarded “Drug Research and Development Science and Technology Golden Award” by the Taiwan Executive Yuan’s Department of Health for six products including Docetaxel, Galantamine, and Irinotecan.
November 2009 Passed management systems accreditation by the Taiwan Responsible Care Association (TRCA) in six categories, including process safety, employee safety, product safety, and emergency response
November 2009 Received management systems accreditation by the “Taiwan Responsible Care Association” (TRCA) in six categories, including process safety, employee safety, product safety, and emergency response
November 2009 Awarded “Outstanding Enterprise Innovation Award” at the Ministry of Economic Affairs’ 17th Annual Industrial Technology Advancement Award ceremony
September 2009 Became first API plant in Asia to receive “High-Potency Synthetic Pharmaceutical Safety certificate” from SafeBridge, an international biotechnology and pharmaceutical occupational safety and hygiene accreditation company
September 2008 Awarded “Outstanding Contribution to Industrial Safety and Hygiene Award” by the Southern Taiwan Science Park Administration
April 2008 Ranked as “Outstanding Business for Harmonious Labor Relations” by the Tainan County Government